GYURIK ROBERT J 4
4 · BENTLEY PHARMACEUTICALS INC · Filed Jan 5, 2004
Insider Transaction Report
Form 4
GYURIK ROBERT J
DirectorVP of Pharm Development
Transactions
- Award
Right to purchase
2004-01-01+50,000→ 50,000 totalExercise: $13.30Exp: 2014-01-01→ Common Stock, $.02 par value (50,000 underlying)
Holdings
- 25,000
Right to purchase
Exercise: $11.81Exp: 2010-03-09→ Common Stock, $.02 par value (25,000 underlying) - 100,000
Right to purchase
Exercise: $9.79Exp: 2012-01-03→ Common Stock, $.02 par value (100,000 underlying) - 10,970(indirect: By IRA)
Common Stock, $.02 par value
- 46,000
Common Stock, $.02 par value
- 40,000
Right to purchase
Exercise: $8.05Exp: 2013-01-01→ Common Stock, $.02 par value (40,000 underlying) - 5,235(indirect: By 401(k))
Common Stock, $.02 par value
- 50,000
Right to purchase
Exercise: $6.00Exp: 2011-05-09→ Common Stock, $.02 par value (50,000 underlying)
Footnotes (7)
- [F1]Options were granted under terms of the Company's 1991 Stock Option Plan. Grant became exercisable on 3/9/2001.
- [F2]Options were granted under terms of the Company's 2001 Employee Stock Option Plan. Grant became exercisable on 5/9/2002.
- [F3]Options were granted under terms of the Company's 2001 Employee Stock Option Plan. Grant became exercisable in two equal installments on 1/3/2003 and 1/3/2004.
- [F4]Options were granted under terms of the Company's 2001 Employee Stock Option Plan. Grant becomes exercisable in two equal installments on 1/1/2004 and 1/1/2005.
- [F5]Options were granted under terms of the Company's 2001 Employee Stock Option Plan. Grant becomes exercisable in two equal installments on 5/21/2004 and 5/21/2005.
- [F6]Options were granted under terms of the Company's 2001 Employee Stock Option Plan. Grant becomes exercisable in two equal installments on 1/1/2005 and 1/1/2006.
- [F7]Includes 928 shares of Common Stock contributed to Reporting Person's 401(k) Plan between May 31, 2003 and December 31, 2003, pursuant to Company-sponsored matching program.